LLY · News · 20260914N

Product Pipeline - Lp(a)

ELI LILLY & Co · 2026-09-14 · Importance 17 · Surprise 24

Novartis reported unfavorable news for its Lp(a)-lowering drug pelacarsen, according to third-party coverage. Eli Lilly is also developing an Lp(a)-lowering therapy, so the competitor’s setback may alter the competitive and regulatory outlook for Lilly’s program. The digest provides no Lilly development milestone, financial commitment, or quantified market impact.

Key facts